[Joint Session] Welcoming Remarks and Keynote Session

Mar 22, 2021 9:00am ‐ Mar 22, 2021 10:10am

Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

Mar 22, 2021 9:35am ‐ Mar 22, 2021 10:10am

A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Mar 22, 2021 10:10am ‐ Mar 22, 2021 10:35am

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Mar 22, 2021 10:10am ‐ Mar 22, 2021 12:00pm

The Gut-Liver Axis in Liver Cancer Risk Conditions

Mar 22, 2021 10:55am ‐ Mar 22, 2021 11:20am

Lipid Dysregulation in Inflammation, NASH, and Cancer

Mar 22, 2021 11:20am ‐ Mar 22, 2021 11:45am

Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Mar 22, 2021 11:45am ‐ Mar 22, 2021 12:00pm

Role of Cancer Associated Fibroblasts in Cholangiocarcinoma

Mar 22, 2021 4:00pm ‐ Mar 22, 2021 4:30pm

Tumor Microenvironment and Hepatobiliary Cancers

Mar 22, 2021 4:00pm ‐ Mar 22, 2021 7:10pm

Mechanisms of Immune Escape in Hepatocellular Carcinoma

Mar 22, 2021 4:30pm ‐ Mar 22, 2021 5:00pm